e.g., angiotensin-converting enzyme inhibitor(s) [ACEi], or angiotensin receptor blockers [ARB]), currently available treatments include sodium-glucose cotransporter 2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP-1 RA), and nonsteroidal mineralocorticoid receptor antagonists (ns-MRA), such as finerenone [5,6,7,8]
His practice focuses on FDA regulatory law and compliance, as well as transactional work in the food and drug, biotechnology, cannabis, hemp, and psychedelics sectors
Editor's Note: This story has been updated to include a statement from Hims & Hers CEO Andrew Dudum.
Fatigue in the early weeks is actually a sign the medication is doing its job your appetite is suppressed, your calorie intake has dropped, and your body is adjusting